Thomas G Auchincloss Net Worth & Insider Trades
Thomas G Auchincloss - Director, Concert Pharmaceuticals, Inc
What is Thomas G Auchincloss's Net Worth?
The current estimated net worth of Concert Pharmaceuticals, Inc's Director, Thomas G Auchincloss, is estimated to be about $1.23M . Thomas G Auchincloss owns about 6,500 units of Concert Pharmaceuticals, Inc common stock. In the last 6 years at Concert Pharmaceuticals, Inc, Thomas G Auchincloss has sold an estimated value of $0 worth.
What is Thomas G Auchincloss's Past Insider Trading?
Thomas G Auchincloss's largest purchase order was 2,000 units , worth over $20.21K on May 16, 2016. In total, Thomas G Auchincloss has made about 8 transactions over 6 years of their time at Concert Pharmaceuticals, Inc. Thomas G Auchincloss usually trades in June, with the busiest year in 2016 and 2020. The most recent transaction was a purchase order of 1,500 units , worth over $12.77K on March 13, 2020.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Thomas Auchincloss
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Thomas G Auchincloss's' Mailing Address?
- Mailing address is C/o Metabolix, Inc. 21 Erie Street Cambridge MA 02139 MA
Concert Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Roger D. Tung | 2020 | $581,967 | - | $1,011,657 | $1,098,957 | $320,082 | $12,114 | $3,024,777 |
| Roger D. Tung | 2019 | $562,287 | - | $1,889,500 | - | $309,258 | $11,304 | $2,772,349 |
| James V. Cassella | 2020 | $450,633 | - | $283,144 | $306,708 | $225,317 | $15,408 | $1,281,210 |
| James V. Cassella | 2019 | $435,394 | - | $708,563 | $319,397 | $217,697 | $13,988 | $1,695,039 |
| Nancy Stuart | 2020 | $444,530 | - | $455,212 | $493,096 | $177,812 | $12,114 | $1,582,764 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1367920/000136792021000022/a2021proxy.htm
What are Concert Pharmaceuticals, Inc's Past Insider Trades?
Concert Pharmaceuticals, Inc's most recent insider trade came on February 16, 2023 by Nancy Stuart who sold 6,048 units worth $50.38K . In the last 9 years, insiders at Concert Pharmaceuticals, Inc have sold an estimated value of $72.41M and bought an estimated value of $26.82M worth of shares. Insider trading is most common in June, with the busiest year in 2015 and 2018. The most active traders at the company are Nancy Stuart, Chief Operating Officer, Roger Tung, Chief Executive Officer, and James Cassella V, Chief Development Officer .
CONCERT PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||